TP53 and cancer: APR-246 (PRIMA-1MET) is a low molecular weight compound, which could restore tumor suppressor activity of mutant p53 and trigger cancer cell apoptosis by upregulating p53 target genes such as BAX, PUMA, and NOXA genes in various cancer types [22].